ALIM NASDAQ
Alimera Sciences, Inc.
1W: +0.2%
1M: -0.9%
3M: +81.6%
1Y: +73.7%
3Y: +0.9%
$5.54
Last traded 2024-09-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2024-06-24
Earliest Filing
2024-09-20
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named ALIM in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| ANIP ANI PHARMACEUTICALS INC | acquirer | Target company acquired by ANI Pharmaceuticals, Inc. in a merger transaction. | 2024-09-20 | View |
| ANIP ANI PHARMACEUTICALS INC | acquirer | Target company in the pending acquisition financed by the new credit facility | 2024-08-13 | View |
| ANIP ANI PHARMACEUTICALS INC | acquirer | Target company in the merger agreement with ANI Pharmaceuticals, Inc. | 2024-06-24 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR